Hepatoid Adenocarcinoma of the Urachus

Table 1

Demographic and clinical data of reported cases.

Case number/reference	Age/sex	Symptoms	Tumor size; (cm)	Serum AFP	Therapy	Stage	Follow-up	Status
(1) Sinard et al. [14]	68/F	Hydronephrosis	2.5	N/A	TUR	T3a	17 months	AWD
(2) Yamada et al. [4]	89/F	Hematuria	6.5 × 5.5	+	TC	T2b	1 month	Unknown
(3) Burgués et al. [5]	71/M	Hematuria	N/A	WNL	TUR	T2	N/A	AWD
(4) Lopez-Beltran et al. [2]	66/M	Hematuria	6.5	+	TC	T3a	14 months	Metastasis, DOD
(5) Lopez-Beltran et al. [2]	85/M	Hematuria	80 g	N/A	TUR	T2	12 months	Metastasis, DOD
(6) Lopez-Beltran et al. [2]	61/M	Hematuria	5 × 5	+	TC	T3a	19 months	Metastasis, DOD
(7) Lopez-Beltran et al. [2]	68/M	Hematuria	1.5	+	TUR	T1	26 months	NED
(8) Kawamura et al. [15]	79/M	Hematuria	1	+	TUR	Ta	19 months	NED
(9) Sekino et al. [6]	49/F	No symptoms	0.6	N/A	TUR	T1	20 months	NED
(10) Present case	51/F	Hematuria	11 × 9	+	PC	T3a	4 months	AWD

AFP: alfa-fetoprotein, AWD: alive with disease, DOD: died of disease, N/A: not available, NED: no evidence of disease, PC: partial cystectomy, TC: total cystectomy, TUR: transurethral resection, and WNL: within normal limits.